NSECertificate under SEBI (Depositories and Participants) Regulations, 20186 Jul 2026 · 6 Jul 2026, 03:52 pm

Certificate under SEBI (Depositories and Participants) Regulations, 2018

Jagsonpal Pharmaceuticals Limited · JAGSNPHARM

✦ AI SummaryRegulatory

Jagsonpal Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended June 30, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk8/10
Balance Sheet Risk3/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Jagsonpal Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

Attachments (1)

📄

JAGSNPHARM_06072026155237_Reg_74_5__Intimation_June_2026.pdf

pdf

Download →
View document text
July 6, 2026 The Department of Corporate Services- Listing The Department of Corporate Services- Listing BSE Ltd, National Stock Exchange of India Ltd Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block G, Dalal Street Bandra Kurla Complex, Mumbai-400 001 Bandra (E) Mumbai – 400 051 Scrip Code: 507789 Symbol: JAGSNPHARM Subject: Certificate in terms of Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 Dear Sir/ Madam, In compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, we are enclosing herewith a copy of the certificate received from M/s MCS Share Transfer Agent Limited, the Registrar and Share Transfer Agent of the Company, for the quarter ended June 30, 2026. We request you to take the above on record. Thanking you, For Jagsonpal Pharmaceuticals Limited Pratham Rawal Company Secretary & Compliance officer MCS Share Transfer Agent Limited 179-180, Dsidc Shed, 3rd Floor Okhla Industrial Area, Phase –I New Delhi –110020 PhoneNo:011-41406149-51,Fax:-011-41709881 ,Email: admin@rmcsregistrars.com Website:www.mcsregistrars.com, CINNO.U67120WB2011PLC165872 Ref. MCSSTA/JSP/06/2026 July 3, 2026 JAGSONPAL PHARMACEUTICALS LIMITED PLOT NO 412-415 3RD FLOOR NIMAI TOWER PH-IV ,UDYOG VIHAR SEC-18 GURUGRAM, HARYANA-122015 Sub: Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the Quarter ended 30th June 2026 Dear Sir/Madam, ln accordance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the Quarter ended 30th June 2026, we hereby certify/ confirm that within 15 days of receipt of the securities received for dematerialization that: (a) the securities comprised in the said Certificate(s) of Security have been listed on the Stock Exchanges where the earlier issued securities are listed ;and (b) the said Certificate(s) after due verification have been mutilated and cancelled and the name of the depository has been substituted in our records as the registered owner. This is for your information and record. Thanking you, Yours faithfully, For MCS Share Transfer Agent Limited Authorised Signatory